An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds. The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, according to results presented Sunday at the American Society of Clinical Oncology (ASCO)…  read on >  read on >

There’s a “loneliness epidemic” in the United States, and feelings of isolation have been linked to heart disease, stroke and other health conditions. Now, new research suggests that cancer survivors who feel lonely may be more likely to die than survivors who have more social support. “Loneliness may be linked to worse survival following a…  read on >  read on >

Many men will put off going to the doctor unless they are really sick, but men’s health screenings help catch problems before symptoms appear. So, how can you tell if a health screening or preventive care appointment is right for you? The U.S. National Institutes of Health (NIH), the Centers for Disease Control and Prevention…  read on >  read on >

Ticks are extremely resilient even when temperatures vary wildly, according to scientists who are working to better understand the spread of Lyme disease. In their new study, black-legged ticks, notorious for carrying pathogens, were very good at surviving both extreme cold and high heat, the scientists found. This was true both for nymph and adult…  read on >  read on >

There is no cure for nearsightedness, but medicated eye drops can slow down its progression in children, a new trial finds. The study tested the effects of eye drops containing a very low dose of the drug atropine — the same medication used to dilate the pupils during an eye exam. Researchers found that when…  read on >  read on >

A former Obama administration official with extensive experience in federal and state health services could be the next leader of the U.S. Centers for Disease Control and Prevention. Former North Carolina Health Secretary Dr. Mandy Cohen is the likely pick, according to sources with knowledge of the plan, the Washington Post reported. Cohen would come…  read on >  read on >